No Impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque model

Molecular Therapy

Volumn 22, Issue 1, 2014, Pages 52-58

  Sellers, Stephanie E ^a   Dumitriu, Bogdan ^a   Morgan, Mary J ^a   Hughes, William M ^a   Wu, Colin O ^a   Raghavarchari, Nalini ^a   Yang, Yanqin ^a   Uchida, Naoya ^a   Tisdale, John F ^a   An, Dong S ^b   Chen, Irvin S ^b   Hematti, Peiman ^c   Donahue, Robert E ^a   LaRochelle, Andre ^a   Young, Neal S ^a   Calado, Rodrigo T ^a   Dunbar, Cynthia E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL 2A1 PROTEIN; CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TRANSFER; GRANULOCYTE; HEMATOPOIETIC STEM CELL; INTERMETHOD COMPARISON; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RHESUS MONKEY; RISK BENEFIT ANALYSIS; STEM CELL GENE THERAPY; STEM CELL TRANSPLANTATION; TELOMERE SHORTENING; VIRAL GENE DELIVERY SYSTEM;

MACACA MULATTA;

ANIMALS; ANTIGENS, CD34; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; TELOMERE; TRANSCRIPTOME; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84891832674     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.168     Document Type: Article

References (49)

1. Cavazzana-Calvo, M, Hacein-Bey, S, de Saint Basile, G, Gross, F, Yvon, E, Nusbaum, P et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672
2. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, McCormack, MP, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419
3. Nienhuis, AW, Dunbar, CE and Sorrentino, BP (2006). Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 13: 1031-1049
4. Ferguson, C, Larochelle, A and Dunbar, CE (2005). Hematopoietic stem cell gene therapy: Dead or alive? Trends Biotechnol 23: 589-597
5. Corrigan-Curay, J, Cohen-Haguenauer, O, O'Reilly, M, Ross, SR, Fan, H, Rosenberg, N et al. (2012). Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Mol Ther 20: 1084-1094
6. Hematti, P, Hong, BK, Ferguson, C, Adler, R, Hanawa, H, Sellers, S et al. (2004). Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol 2: E423
7. Schwarzwaelder, K, Howe, SJ, Schmidt, M, Brugman, MH, Deichmann, A, Glimm, H et al. (2007). Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest 117: 2241-2249
8. Howe, SJ, Mansour, MR, Schwarzwaelder, K, Bartholomae, C, Hubank, M, Kempski, H et al. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143-3150
9. Schröder, AR, Shinn, P, Chen, H, Berry, C, Ecker, JR and Bushman, F (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529
10. Beard, BC, Dickerson, D, Beebe, K, Gooch, C, Fletcher, J, Okbinoglu, T et al. (2007). Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 15: 1356-1365
11. De Palma, M, Montini, E, Santoni de Sio, FR, Benedicenti, F, Gentile, A, Medico, E et al. (2005). Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 105: 2307-2315
12. Montini, E, Cesana, D, Schmidt, M, Sanvito, F, Bartholomae, CC, Ranzani, M et al. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119: 964-975
13. Modlich, U, Navarro, S, Zychlinski, D, Maetzig, T, Knoess, S, Brugman, MH et al. (2009). Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 17: 1919-1928
14. Kim, YJ, Kim, YS, Larochelle, A, Renaud, G, Wolfsberg, TG, Adler, R et al. (2009). Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vectortransduced CD34+ cells. Blood 113: 5434-5443
15. Calmels, B, Ferguson, C, Laukkanen, MO, Adler, R, Faulhaber, M, Kim, HJ et al. (2005). Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 106: 2530-2533
16. Cartier, N, Hacein-Bey-Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, I et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823
17. Cavazzana-Calvo, M, Payen, E, Negre, O, Wang, G, Hehir, K, Fusil, F et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human ß-thalassaemia. Nature 467: 318-322
18. Ikeda, K, Mason, PJ and Bessler, M (2011). 3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice. Blood 117: 5860-5869
19. Cesana, D, Sgualdino, J, Rudilosso, L, Merella, S, Naldini, L and Montini, E (2012). Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. J Clin Invest 122: 1667-1676
20. Donahue, RE and Dunbar, CE (2001). Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells. Hum Gene Ther 12: 607-617
21. Shepherd, BE, Kiem, HP, Lansdorp, PM, Dunbar, CE, Aubert, G, LaRochelle, A et al. (2007). Hematopoietic stem-cell behavior in nonhuman primates. Blood 110: 1806-1813
22. Vaziri, H, Dragowska, W, Allsopp, RC, Thomas, TE, Harley, CB and Lansdorp, PM (1994). Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860
23. Lansdorp, PM (2008). Telomeres, stem cells, and hematology. Blood 111: 1759-1766
24. Kim, S, Kim, N, Presson, AP, An, DS, Mao, SH, Bonifacino, AC et al. (2010). Highthroughput, sensitive quantification of repopulating hematopoietic stem cell clones. J Virol 84: 11771-11780
25. Seggewiss, R, Pittaluga, S, Adler, RL, Guenaga, FJ, Ferguson, C, Pilz, IH et al. (2006). Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque. Blood 107: 3865-3867
26. Futreal, PA, Coin, L, Marshall, M, Down, T, Hubbard, T, Wooster, R et al. (2004). A census of human cancer genes. Nat Rev Cancer 4: 177-183
27. Shepherd, BE, Guttorp, P, Lansdorp, PM and Abkowitz, JL (2004). Estimating human hematopoietic stem cell kinetics using granulocyte telomere lengths. Exp Hematol 32: 1040-1050
28. Allsopp, RC, Cheshier, S and Weissman, IL (2001). Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 193: 917-924
29. Yamada, O, Oshimi, K, Motoji, T and Mizoguchi, H (1995). Telomeric DNA in normal and leukemic blood cells. J Clin Invest 95: 1117-1123
30. Sakoff, JA, De Waal, E, Garg, MB, Denham, J, Scorgie, FE, Enno, A et al. (2002). Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood. Leuk Lymphoma 43: 2017-2020
31. Steinert, S, White, DM, Zou, Y, Shay, JW and Wright, WE (2002). Telomere biology and cellular aging in nonhuman primate cells. Exp Cell Res 272: 146-152
32. Shimizu, Y, Suzuki, J, Terao, K and Ishida, T (2003). In vitro aging of macaque adherent cells: Similar pattern of cellular aging between human and macaque. Mech Ageing Dev 124: 237-244
33. Baerlocher, GM, Mak, J, Röth, A, Rice, KS and Lansdorp, PM (2003). Telomere shortening in leukocyte subpopulations from baboons. J Leukoc Biol 73: 289-296
34. Harley, CB, Futcher, AB and Greider, CW (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460
35. Notaro, R, Cimmino, A, Tabarini, D, Rotoli, B and Luzzatto, L (1997). In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci USA 94: 13782- 13785
36. Wynn, RF, Cross, MA, Hatton, C, Will, AM, Lashford, LS, Dexter, TM et al. (1998). Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 351: 178-181
37. Calado, RT, Cooper, JN, Padilla-Nash, HM, Sloand, EM, Wu, CO, Scheinberg, P et al. (2012). Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia 26: 700-707
38. Recchia, A, Bonini, C, Magnani, Z, Urbinati, F, Sartori, D, Muraro, S et al. (2006). Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc Natl Acad Sci USA 103: 1457-1462
39. Ott, MG, Schmidt, M, Schwarzwaelder, K, Stein, S, Siler, U, Koehl, U et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409
40. Donahue, RE, Kuramoto, K and Dunbar, CE (2005). Large animal models for stem and progenitor cell analysis. Curr Protoc Immunol Chapter 22: Unit 22A.1
41. Kelly, PF, Donahue, RE, Vandergriff, JA, Takatoku, M, Bonifacino, AC, Agricola, BA et al. (2003). Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with a RD114 pseudotyped oncoretroviral vector. Blood Cells Mol Dis 30: 132-143
42. Hanawa, H, Hematti, P, Keyvanfar, K, Metzger, ME, Krouse, A, Donahue, RE et al. (2004). Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103: 4062-4069
43. Uchida, N, Washington, KN, Hayakawa, J, Hsieh, MM, Bonifacino, AC, Krouse, AE et al. (2009). Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells. J Virol 83: 9854-9862
44. Uchida, N, Hargrove, PW, Lap, CJ, Evans, ME, Phang, O, Bonifacino, AC et al. (2012). High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector. Mol Ther 20: 1882-1892
45. An, DS, Kung, SK, Bonifacino, A, Wersto, RP, Metzger, ME, Agricola, BA et al. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gammachain cytokine receptor in rhesus macaques. J Virol 75: 3547-3555
46. Sander, WE, Metzger, ME, Morizono, K, Bonifacino, A, Penzak, SR, Xie, YM et al. (2006). Noninvasive molecular imaging to detect transgene expression of lentiviral vector in nonhuman primates. J Nucl Med 47: 1212-1219
47. Weber, K, Mock, U, Petrowitz, B, Bartsch, U and Fehse, B (2010). Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: New building blocks for cell marking and multi-gene analysis. Gene Ther 17: 511-520
48. Cawthon, RM (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res 30: E47
49. Brouilette, SW, Moore, JS, McMahon, AD, Thompson, JR, Ford, I, Shepherd, J et al.; West of Scotland Coronary Prevention Study Group. (2007). Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet 369: 107-114